Connect with us
Janssen and Novartis are some of the big winners of this contract, which is divided into more than twenty different lots. Novartis has been awarded the...
Various organizations in different countries are seeking solutions that can prevent or combat the new coronavirus and prevent its expansion. A team of scientists and businessmen...
The biotech company Seqens announced that it is prepared to begin large scale production of hydroxychloroquine. According to the company, the needs for this treatment could...
With the $12 million (€11 million) financing, Bone Therapeutics will be able to continue its activities until the first quarter of 2021. Once markets return to...
Ivermectin is being researched to evaluate its efficacy in the treatment of COVID-19. In the event of positive results, MedinCell may position a long-acting version of...
The biopharmaceutical company Theranexus has just completed the Phase 2 trial of its THN102 drug candidate in Parkinson's disease. The study demonstrated the efficacy of THN102...
The Sarconeos clinical program should soon be tested at the Pitié-Salpêtrière Hospital in patients with coronavirus. This active molecule of natural origin is already being tested...
Not all companies have lost money due to the coronavirus outbreak and the historic fall in global markets in recent days. There are firms which, due...
An Israeli company, named BATM Advanced Communications Ltd, has developed a new coronavirus diagnostic kit, cheaper than the one used in all the laboratories around the...
Transmural Biotech, a company in which Asisa holds a majority stake, responds to an unresolved clinical need through quantusFLM: Neonatal Respiratory Morbidity (NRM) being the main...